These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 683893)
1. [Effectiveness of L-aspartate of erythromycin A cyclic carbonate, a new Polish semisynthetic antibiotic in systemic infections caused by staphylococci and in pneumococcal pneumonia in mice]. Kadłubowski R; Kurnatowska A; Bojarska-Dahlig H Pol Tyg Lek; 1978 May; 33(21):861-3. PubMed ID: 683893 [No Abstract] [Full Text] [Related]
2. L-aspartate of erythromycin A cyclic 11,12-carbonate, a new semisynthetic erythromycin derivative. Bojarska-Dahlig H; Slawinski W; Roślik-Kamińska D; Schaeffer A; Kryzsiak A; Dziliński E; Skibińska I; Prussak-Wieckowska T; Kotula W; Kadlubowski R; Kurnatowska A J Antibiot (Tokyo); 1976 Sep; 29(9):907-14. PubMed ID: 1033178 [TBL] [Abstract][Full Text] [Related]
3. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. Rahal JJ N Engl J Med; 1994 Dec; 331(26):1774-5. PubMed ID: 7984204 [No Abstract] [Full Text] [Related]
8. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia]. Veber B; Pocidalo JJ Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075 [TBL] [Abstract][Full Text] [Related]
10. Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy. Butler JC; Lennox JL; McDougal LK; Sutcliffe JA; Tait-Kamradt A; Tenover FC Clin Infect Dis; 2003 Jan; 36(2):e19-25. PubMed ID: 12522763 [TBL] [Abstract][Full Text] [Related]
11. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. Godin B; Touitou E; Rubinstein E; Athamna A; Athamna M J Antimicrob Chemother; 2005 Jun; 55(6):989-94. PubMed ID: 15857943 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice. Männistö PT; Hanhijärvi H; Havas A; Vuorela A; Komulainen H; Rauramaa V J Pharmacol Exp Ther; 1989 Sep; 250(3):1028-33. PubMed ID: 2778707 [TBL] [Abstract][Full Text] [Related]
13. Pneumonia. Pagano JS; Sarubbi FA Am Fam Physician; 1972 Dec; 6(6):84-91. PubMed ID: 4642154 [No Abstract] [Full Text] [Related]
14. [Clinical significance of Streptococcus pneumoniae resistance to erythromycin]. Ruiz Montes FR; Falguera Sacrest M; Teixidó Fo B; Rubbio Caballero M Med Clin (Barc); 1990 May; 94(19):758-9. PubMed ID: 2388509 [No Abstract] [Full Text] [Related]
16. Pneumonia caused by a pneumococcus resistant to erythromycin and lincomycin. Case report. Medoff G Mo Med; 1974 Aug; 71(8):496-7. PubMed ID: 4152480 [No Abstract] [Full Text] [Related]
17. Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models. Fernandes PB; Swanson RN; Hardy DJ; McDonald EJ; Ramer N Drugs Exp Clin Res; 1988; 14(7):441-4. PubMed ID: 2977115 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapeutic effectiveness of antibiotics in combination with papain in experimental septicemia]. Baskanchiladze GSh; Khurtsilava LA; Gelovani IA; Asatiani MV; Rossinskii VI Antibiotiki; 1984 Jan; 29(1):33-5. PubMed ID: 6696400 [TBL] [Abstract][Full Text] [Related]
19. Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse. Bédos JP; Azoulay-Dupuis E; Vallée E; Veber B; Pocidalo JJ J Antimicrob Chemother; 1992 Jun; 29(6):677-85. PubMed ID: 1387132 [TBL] [Abstract][Full Text] [Related]
20. [Use of a chloramphenicol-erythromycin combination in the treatment of lung diseases in children]. da Silva WB; Collesi O; Schvartsman S Hospital (Rio J); 1968 Jan; 73(1):201-6. PubMed ID: 5308493 [No Abstract] [Full Text] [Related] [Next] [New Search]